Literature DB >> 8785588

A purine-rich sequence in the human BM-40 gene promoter region is a prerequisite for maximum transcription.

M Hafner1, K Zimmermann, J Pottgiesser, T Krieg, R Nischt.   

Abstract

BM-40 (osteonectin, SPARC [secreted protein, acidic, rich in cysteine]) is a highly conserved, matrix-associated protein that is found in basement membranes, bones and remodeling tissues throughout vertebrate evolution. We are reporting the characterization of the 5' end of the human BM-40 gene. Sequence comparison of the 5' region revealed significant homologies with the bovine and murine genes, including a purine-rich stretch composed of two boxes, GGA-box 1 and 2, separated by a pyrimidine-rich spacer element. Transfection analyses of the human BM-40 promoter provide strong evidence that this region comprises several distinct regulatory domains, to which different functions can be assigned. GGA-box 1 is thereby absolutely required and sufficient by itself for maximal BM-40 transcriptional activity, whereas the spacer element has a down-regulatory effect. Comparative transfection analyses in human cell lines, positive or negative for BM-40 transcripts, indicate that the GGA-box sequences in the human promoter, in contrast to the bovine promoter, do not significantly contribute to cell-type specific expression in human cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8785588     DOI: 10.1016/s0945-053x(05)80016-2

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  11 in total

1.  miR-29 suppression of osteonectin in osteoblasts: regulation during differentiation and by canonical Wnt signaling.

Authors:  Kristina Kapinas; Catherine B Kessler; Anne M Delany
Journal:  J Cell Biochem       Date:  2009-09-01       Impact factor: 4.429

2.  Identification of an intronic enhancer that nullifies upstream repression of SPARC gene expression.

Authors:  K Satyamoorthy; S J Samulewicz; L D Thornburg; A Basu; C C Howe
Journal:  Nucleic Acids Res       Date:  1997-08-01       Impact factor: 16.971

3.  Therapeutic improvement of a stroma-targeted CRAd by incorporating motives responsive to the melanoma microenvironment.

Authors:  Diego L Viale; Eduardo G Cafferata; David Gould; Cecilia Rotondaro; Yuti Chernajovsky; David T Curiel; Osvaldo L Podhajcer; M Veronica Lopez
Journal:  J Invest Dermatol       Date:  2013-04-19       Impact factor: 8.551

4.  Osteonectin/SPARC polymorphisms in Caucasian men with idiopathic osteoporosis.

Authors:  A M Delany; D J McMahon; J S Powell; D A Greenberg; E S Kurland
Journal:  Osteoporos Int       Date:  2007-12-15       Impact factor: 4.507

5.  Expression of a suicidal gene under control of the human secreted protein acidic and rich in cysteine (SPARC) promoter in tumor or stromal cells led to the inhibition of tumor cell growth.

Authors:  María V Lopez; Patricia Blanco; Diego L Viale; Eduardo G Cafferata; Cecilia Carbone; David Gould; Yuti Chernajovsky; Osvaldo L Podhajcer
Journal:  Mol Cancer Ther       Date:  2006-10       Impact factor: 6.261

6.  Control of gene expression by the retinoic acid-related orphan receptor alpha in HepG2 human hepatoma cells.

Authors:  Caroline Chauvet; Amandine Vanhoutteghem; Christian Duhem; Gaëlle Saint-Auret; Brigitte Bois-Joyeux; Philippe Djian; Bart Staels; Jean-Louis Danan
Journal:  PLoS One       Date:  2011-07-26       Impact factor: 3.240

7.  Co-Targeting Prostate Cancer Epithelium and Bone Stroma by Human Osteonectin-Promoter-Mediated Suicide Gene Therapy Effectively Inhibits Androgen-Independent Prostate Cancer Growth.

Authors:  Shian-Ying Sung; Junn-Liang Chang; Kuan-Chou Chen; Shauh-Der Yeh; Yun-Ru Liu; Yen-Hao Su; Chia-Yen Hsueh; Leland W K Chung; Chia-Ling Hsieh
Journal:  PLoS One       Date:  2016-04-07       Impact factor: 3.240

8.  Tumor associated stromal cells play a critical role on the outcome of the oncolytic efficacy of conditionally replicative adenoviruses.

Authors:  M Verónica Lopez; Diego L Viale; Eduardo G A Cafferata; Alicia I Bravo; Cecilia Carbone; David Gould; Yuti Chernajovsky; Osvaldo L Podhajcer
Journal:  PLoS One       Date:  2008-04-08       Impact factor: 3.240

9.  A novel G-quadruplex-forming GGA repeat region in the c-myb promoter is a critical regulator of promoter activity.

Authors:  SunMi L Palumbo; Regan M Memmott; Diana J Uribe; Yulia Krotova-Khan; Laurence H Hurley; Scot W Ebbinghaus
Journal:  Nucleic Acids Res       Date:  2008-02-05       Impact factor: 16.971

10.  Possibility for Transcriptional Targeting of Cancer-Associated Fibroblasts-Limitations and Opportunities.

Authors:  Dina V Antonova; Marina V Zinovyeva; Liya G Kondratyeva; Alexander V Sass; Irina V Alekseenko; Victor V Pleshkan
Journal:  Int J Mol Sci       Date:  2021-03-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.